Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Change in Receivables (2022 - 2025)

HeartSciences (HSCS) has disclosed Change in Receivables for 3 consecutive years, with -$4350.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables changed N/A year-over-year to -$4350.0, compared with a TTM value of $6450.0 through Oct 2025, changed N/A, and an annual FY2025 reading of $4350.0, changed N/A over the prior year.
  • Change in Receivables was -$4350.0 for Q3 2025 at HeartSciences, down from $10800.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $10800.0 in Q1 2024 and bottomed at -$4350.0 in Q3 2025.
  • Average Change in Receivables over 3 years is $1376.3, with a median of -$2321.0 recorded in 2022.